• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全国抑郁症及躁郁症协会关于抑郁症治疗不足的共识声明。

The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression.

作者信息

Hirschfeld R M, Keller M B, Panico S, Arons B S, Barlow D, Davidoff F, Endicott J, Froom J, Goldstein M, Gorman J M, Marek R G, Maurer T A, Meyer R, Phillips K, Ross J, Schwenk T L, Sharfstein S S, Thase M E, Wyatt R J

机构信息

National Depressive and Manic-Depressive Association, Chicago, IL, USA.

出版信息

JAMA. 1997;277(4):333-40.

PMID:9002497
Abstract

OBJECTIVE

A consensus conference on the reasons for the undertreatment of depression was organized by the National Depressive and Manic Depressive Association (NDMDA) on January 17-18, 1996. The target audience included health policymakers, clinicians, patients and their families, and the public at large. Six key questions were addressed: (1) Is depression undertreated in the community and in the clinic? (2) What is the economic cost to society of depression? (3) What have been the efforts in the past to redress undertreatment and how successful have they been? (4) What are the reasons for the gap between our knowledge of the diagnosis and treatment of depression and actual treatment received in this country? (5) What can we do to narrow this gap? (6) What can we do immediately to narrow this gap?

PARTICIPANTS

Consensus panel members were drawn from psychiatry, psychology, family practice, internal medicine, managed care and public health, consumers, and the general public. The panelists listened to a set of presentations with background papers from experts on diagnosis, epidemiology, treatment, and cost of treatment.

EVIDENCE

Experts summarized relevant data from the world scientific literature on the 6 questions posed for the conference.

CONSENSUS PROCESS

Panel members discussed openly all material presented to them in executive session. Selected panelists prepared first drafts of the consensus statements for each question. All of these drafts were read by all panelists and were edited and reedited until consensus was achieved.

CONCLUSIONS

There is overwhelming evidence that individuals with depression are being seriously undertreated. Safe, effective, and economical treatments are available. The cost to individuals and society of this undertreatment is substantial. Long suffering, suicide, occupational impairment, and impairment in interpersonal and family relationships exist. Efforts to redress this gap have included provider educational programs and public educational programs. Reasons for the continuing gap include patient, provider, and health care system factors. Patient-based reasons include failure to recognize the symptoms, underestimating the severity, limited access, reluctance to see a mental health care specialist due to stigma, noncompliance with treatment, and lack of health insurance. Provider factors include poor professional school education about depression, limited training in interpersonal skills, stigma, inadequate time to evaluate and treat depression, failure to consider psychotherapeutic approaches, and prescription of inadequate doses of antidepressant medication for inadequate durations. Mental health care systems create barriers to receiving optimal treatment. Strategies to narrow the gap include enhancing the role of patients and families as participants in care and advocates; developing performance standards for behavioral health care systems, including incentives for positive identification, assessment, and treatment of depression; enhancing educational programs for providers and the public; enhancing collaboration among provider subtypes (eg, primary care providers and mental health professionals); and conducting research on development and testing of new treatments for depression.

摘要

目标

1996年1月17日至18日,全国抑郁症及躁郁症协会(NDMDA)组织了一次关于抑郁症治疗不足原因的共识会议。目标受众包括卫生政策制定者、临床医生、患者及其家属以及广大公众。会议探讨了六个关键问题:(1)社区和诊所中抑郁症是否治疗不足?(2)抑郁症给社会带来的经济成本是多少?(3)过去为纠正治疗不足做出了哪些努力,成效如何?(4)我国在抑郁症诊断和治疗方面的知识与实际接受的治疗之间存在差距的原因是什么?(5)我们能做些什么来缩小这一差距?(6)我们能立即采取什么措施来缩小这一差距?

参与者

共识小组成员来自精神病学、心理学、家庭医学、内科、管理式医疗和公共卫生领域,以及消费者和普通公众。小组成员听取了一系列由诊断、流行病学、治疗和治疗成本方面的专家提供的背景文件介绍。

证据

专家们总结了世界科学文献中与会议提出的六个问题相关的数据。

共识形成过程

小组成员在执行会议上公开讨论了提交给他们的所有材料。选定的小组成员为每个问题起草了共识声明的初稿。所有这些初稿都由所有小组成员阅读,并经过编辑和反复编辑,直至达成共识。

结论

有压倒性的证据表明,抑郁症患者的治疗严重不足。安全、有效且经济的治疗方法是可用的。这种治疗不足给个人和社会带来的成本巨大。存在长期痛苦、自杀、职业障碍以及人际关系和家庭关系受损的情况。为缩小这一差距所做的努力包括针对医疗服务提供者的教育项目和公众教育项目。持续存在差距的原因包括患者、医疗服务提供者和医疗保健系统等因素。基于患者的原因包括未能识别症状、低估病情严重程度、就医机会有限、因污名化而不愿看心理健康专家、不遵守治疗方案以及缺乏医疗保险。医疗服务提供者方面的因素包括专业院校对抑郁症的教育不足、人际技能培训有限、污名化、评估和治疗抑郁症的时间不足、未考虑心理治疗方法以及抗抑郁药物剂量不足且疗程不够。心理健康保健系统为获得最佳治疗设置了障碍。缩小差距的策略包括增强患者及其家属作为护理参与者和倡导者的作用;制定行为健康保健系统的绩效标准,包括对积极识别、评估和治疗抑郁症的激励措施;加强针对医疗服务提供者和公众的教育项目;加强不同类型医疗服务提供者(如初级保健提供者和心理健康专业人员)之间的合作;以及开展关于抑郁症新治疗方法的研发和测试研究。

相似文献

1
The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression.全国抑郁症及躁郁症协会关于抑郁症治疗不足的共识声明。
JAMA. 1997;277(4):333-40.
2
Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society.阿尔茨海默病及相关疾病的诊断与治疗。美国老年精神病学协会、阿尔茨海默病协会及美国老年医学会的共识声明。
JAMA. 1997;278(16):1363-71.
3
Diagnosis and treatment of depression in late life. Consensus statement update.老年期抑郁症的诊断与治疗。共识声明更新
JAMA. 1997 Oct 8;278(14):1186-90.
4
A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.一个就注意力缺陷/多动障碍的诊断和管理达成社区共识的过程。
Pediatrics. 2005 Jan;115(1):e97-104. doi: 10.1542/peds.2004-0953.
5
Diagnosis and treatment of attention deficit hyperactivity disorder (ADHD).注意缺陷多动障碍(ADHD)的诊断与治疗。
NIH Consens Statement. 1998;16(2):1-37.
6
A 47-year-old man with chronic depression.一名患有慢性抑郁症的47岁男性。
JAMA. 1996 Feb 14;275(6):479-85.
7
Pediatric primary care providers and adolescent depression: a qualitative study of barriers to treatment and the effect of the black box warning.儿科初级保健提供者与青少年抑郁症:关于治疗障碍及黑框警告影响的定性研究
J Adolesc Health. 2007 May;40(5):433-9. doi: 10.1016/j.jadohealth.2006.12.006. Epub 2007 Feb 15.
8
National Institutes of Health State-of-the-Science Conference Statement: Symptom management in cancer: pain, depression, and fatigue, July 15-17, 2002.美国国立卫生研究院科学现状会议声明:癌症症状管理:疼痛、抑郁和疲劳,2002年7月15 - 17日
J Natl Cancer Inst Monogr. 2004(32):9-16. doi: 10.1093/jncimonographs/djg014.
9
NIH State-of-the-Science Conference Statement on manifestations and management of chronic insomnia in adults.美国国立卫生研究院关于成人慢性失眠的表现与管理的科学现状会议声明。
NIH Consens State Sci Statements. 2005;22(2):1-30.
10
[Undertreatment of depression; causes and recommendations].[抑郁症治疗不足;原因与建议]
Ned Tijdschr Geneeskd. 2003 May 24;147(21):1005-9.

引用本文的文献

1
Mental Health Service Type Use and Depressive Symptoms: A Multivariable Analysis of Sociodemographic Correlates: Utilisation des services de santé mentale et symptômes dépressifs : Analyse multi-variables des corrélats sociodémographiques.心理健康服务类型的使用与抑郁症状:社会人口统计学相关因素的多变量分析:心理健康服务利用情况与抑郁症状:社会人口统计学相关因素的多变量分析
Can J Psychiatry. 2025 Jun 3:7067437251347149. doi: 10.1177/07067437251347149.
2
Dose-dependent effects of transcranial photobiomodulation on brain temperature in patients with major depressive disorder: a spectroscopy study.经颅光生物调节对重度抑郁症患者脑温的剂量依赖性影响:一项光谱学研究。
Lasers Med Sci. 2024 Oct 7;39(1):249. doi: 10.1007/s10103-024-04198-6.
3
Effects of pain, hospitalization, and medication on depressive symptom in Syrian patients with chronic diseases.
疼痛、住院和药物对叙利亚慢性病患者抑郁症状的影响。
Sci Rep. 2024 Sep 5;14(1):20751. doi: 10.1038/s41598-024-71543-8.
4
Lifestyle causal beliefs are associated with higher personal and perceived stigma regarding depressive disorders: results from a representative population survey.生活方式因果信念与更高的个人和感知耻辱感有关抑郁障碍:来自代表性人口调查的结果。
BMC Psychiatry. 2023 Jun 8;23(1):414. doi: 10.1186/s12888-023-04907-5.
5
Prescription Drug Advertising and Drug Utilization: The Role of Medicare Part D.处方药广告与药物利用:医疗保险D部分的作用
J Public Econ. 2023 May;221. doi: 10.1016/j.jpubeco.2023.104860. Epub 2023 Mar 17.
6
Should Antidepressants be Avoided in Pregnancy?抗抑郁药在孕期应避免使用吗?
Drug Saf. 2023 Jan;46(1):1-17. doi: 10.1007/s40264-022-01257-1. Epub 2022 Dec 20.
7
School-based Mental Health Interventions Targeting Depression or Anxiety: A Meta-analysis of Rigorous Randomized Controlled Trials for School-aged Children and Adolescents.学校为基础的针对抑郁或焦虑的心理健康干预措施:针对学龄儿童和青少年的严格随机对照试验的荟萃分析。
J Youth Adolesc. 2023 Jan;52(1):195-217. doi: 10.1007/s10964-022-01684-4. Epub 2022 Oct 13.
8
Cervical muscle stiffness and parasympathetic nervous system improvements for treatment-resistant depression.治疗抵抗性抑郁症的颈肌僵硬和副交感神经系统改善。
BMC Musculoskelet Disord. 2022 Oct 11;23(1):907. doi: 10.1186/s12891-022-05860-2.
9
SNAP work requirements increase mental health care use."SNAP 工作要求增加了心理健康保健的使用。"
Health Serv Res. 2023 Feb;58(1):60-66. doi: 10.1111/1475-6773.14033. Epub 2022 Jul 27.
10
Diagnostic accuracy of the Patient Health Questionnaire 2 (PHQ-2) in Qatar's primary care settings.卡塔尔基层医疗环境中患者健康问卷 2(PHQ-2)的诊断准确性。
Prim Health Care Res Dev. 2022 Jan 31;23:e5. doi: 10.1017/S146342362100089X.